CTSO

Cytosorbents Corporation Common Stock NASDAQ Capital Market
$3.44
Open: $3.42 High: $3.79 Low: $3.24 Close: $3.24
Range: 2022-01-20 - 2022-01-21
Volume:633,412
Market: Closed
CTSO
Cytosorbents Corporation Common Stock 7 Deer Park Drive Monmouth Junction NJ, 8852 http://www.cytosorbents.com
CytoSorbents Corp is a immunotherapy company. The Company uses blood purification to modulate inflammation with the goal of preventing or treating multiple organ failure in life-threatening illnesses and cardiac surgery.
  • CEO: Phillip P. Chan
  • Employees: 101
  • Sector: Healthcare
  • Industry: Medical Diagnostics & Research
Latest Stocks Posts
Card image
Card image
Card image
CTSO News
Latest news about the CTSO